Brokerages Set Phibro Animal Health Corp. (PAHC) Price Target at $26.80
Phibro Animal Health Corp. (NASDAQ:PAHC) has been given an average recommendation of “Hold” by the eight research firms that are presently covering the stock. Three equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $26.80.
Several research firms have weighed in on PAHC. Morgan Stanley set a $23.00 target price on Phibro Animal Health Corp. and gave the stock a “sell” rating in a report on Sunday, September 4th. Zacks Investment Research lowered Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, August 23rd. Guggenheim set a $30.00 target price on Phibro Animal Health Corp. and gave the stock a “buy” rating in a report on Monday, September 12th. Macquarie lowered Phibro Animal Health Corp. from a “neutral” rating to an “underperform” rating and set a $21.00 target price on the stock. in a report on Friday, November 11th. Finally, Credit Suisse Group AG reiterated a “buy” rating and set a $29.00 target price on shares of Phibro Animal Health Corp. in a report on Tuesday, August 30th.
Hedge funds have recently modified their holdings of the stock. BlackRock Fund Advisors raised its stake in Phibro Animal Health Corp. by 2.8% in the third quarter. BlackRock Fund Advisors now owns 1,509,360 shares of the company’s stock valued at $41,024,000 after buying an additional 41,291 shares during the last quarter. Thornburg Investment Management Inc. raised its stake in Phibro Animal Health Corp. by 20.8% in the second quarter. Thornburg Investment Management Inc. now owns 1,327,077 shares of the company’s stock valued at $24,763,000 after buying an additional 228,171 shares during the last quarter. RidgeWorth Capital Management LLC bought a new stake in Phibro Animal Health Corp. during the second quarter valued at about $24,107,000. BlackRock Advisors LLC raised its stake in Phibro Animal Health Corp. by 29.3% in the third quarter. BlackRock Advisors LLC now owns 683,795 shares of the company’s stock valued at $18,586,000 after buying an additional 154,944 shares during the last quarter. Finally, Denver Investment Advisors LLC raised its stake in Phibro Animal Health Corp. by 13.6% in the second quarter. Denver Investment Advisors LLC now owns 576,020 shares of the company’s stock valued at $10,749,000 after buying an additional 69,092 shares during the last quarter. Institutional investors own 47.58% of the company’s stock.
Phibro Animal Health Corp. (NASDAQ:PAHC) opened at 28.05 on Tuesday. Phibro Animal Health Corp. has a one year low of $16.80 and a one year high of $35.69. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of 14.69 and a beta of 1.38. The stock’s 50 day moving average price is $26.70 and its 200-day moving average price is $22.77.
Phibro Animal Health Corp. (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, November 9th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.02. Phibro Animal Health Corp. had a return on equity of 75.49% and a net margin of 10.13%. The business earned $188 million during the quarter, compared to analysts’ expectations of $188.85 million. During the same period in the previous year, the firm earned $0.44 earnings per share. The firm’s quarterly revenue was up .5% compared to the same quarter last year. Analysts forecast that Phibro Animal Health Corp. will post $1.42 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 21st. Stockholders of record on Wednesday, November 30th will be issued a $0.10 dividend. The ex-dividend date is Monday, November 28th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.43%. Phibro Animal Health Corp.’s dividend payout ratio (DPR) is 21.05%.
TRADEMARK VIOLATION WARNING: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2016/11/25/brokerages-set-phibro-animal-health-corp-pahc-price-target-at-26-80.html.
Phibro Animal Health Corp. Company Profile
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.
Receive News & Stock Ratings for Phibro Animal Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp. and related stocks with our FREE daily email newsletter.